Prostate-specific antigen for staging prior to surgery and for early detection of recurrence after surgery
Lange, P.H.
Urologic Clinics of North America 17(4): 813-817
1990
ISSN/ISBN: 0094-0143 PMID: 1699343 Document Number: 357598
The exact usefulness of prostate-specific antigen for staging before radical prostatectomy is still unclear. Perhaps the marker's most exciting feature is its value in detecting residual disease after radical prostatectomy. The author also discusses the technical questions in testing and interpretation.
Document emailed within 1 workday
Related Documents
Galić, J.; Karner, I.; Cenan, L.; Tucak, A.; Hegedus, I.; Pasini, J.; Bilandzija-Peranović, M.; Mihaljević, S. 2003: Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer Collegium Antropologicum 27(Suppl 1): 61-66Maeda, H.; Arai, Y.; Ishitoya, S.; Okubo, K.; Aoki, Y.; Okada, T.; Maekawa, S. 1998: Free-to-total prostate specific antigen ratio in clinical staging of prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 44(5): 307-311
Jung, P.; Wolff, J.M.; Mattelaer, P.; Jakse, G. 1996: Prostate specific antigen in the diagnosis and staging of prostate cancer Acta Urologica Belgica 64(3): 1-6
Schröder, F.H. 2007: Words of wisdom. Re: detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability European Urology 52(3): 922
De la Taille, A.; Houlgatte, A.; Houdelette, P.; Berlizot, P.; Ramirez, J.; Ricordel, I. 1997: Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients) Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(2): 240-245
Topuzov, M.E. 2007: Role of density of prostate-specific antigen transitory zone in early diagnosis of prostate cancer Voprosy Onkologii 53(3): 295-297
Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Chen, J.-C.; Ho, C.-L.; Tsai, H.-W.; Tzai, T.-S.; Liu, H.-S.; Chow, N.-H.; Yang, W.-H.; Cheng, H.-L. 2008: Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder Anticancer Research 28(6b): 4149-4154
Galvan, B.; Christopoulos, T.K.; Diamandis, E.P. 1995: Detection of prostate-specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry Clinical Chemistry 41(12 Part 1): 1705-1709
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Hobbs, M.M.; Steiner, M.J.; Rich, K.D.; Gallo, M.F.; Alam, A.; Rahman, M.; Menezes, P.; Chipato, T.; Warner, L.; Macaluso, M. 2009: Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research Sexually Transmitted Diseases 36(8): 501-506
Peonim, V.; Chirachariyavej, T.; Atamasirikul, K.; Talthip, J. 2007: Comparable between rapid one step immunochromatographic assay and ELISA in the detection of prostate specific antigen in vaginal specimens of raped women Journal of the Medical Association of Thailand 90(12): 2624-2629
Snead, M.C.; Melendez, J.H.; Kourtis, A.P.; Chaney, D.M.; Brown, T.M.; Black, C.M.; Mauck, C.K.; Schwartz, J.L.; Zenilman, J.M.; Jamieson, D.J.; Macaluso, M.; Doncel, G.F. 2014: Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay Contraception 89(2): 134-138
Nixon, R.G.; Lilly, J.D.; Liedtke, R.J.; Batjer, J.D. 1997: Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen Archives of Pathology and Laboratory Medicine 121(4): 385-391
De la Taille, A.; Cao, Y.; Sawczuk, I.S.; Nozemu, T.; d'Agati, V.; McKiernan, J.M.; Bagiella, E.; Buttyan, R.; Burchardt, M.; Olsson, C.A.; Bander, N.; Katz, A.E. 2000: Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion Cancer Detection and Prevention 24(6): 579-588
Joosten, F.B.; Verbeek, A.L.; Bruggink, E.D.; Wobbes, T.; Rosenbusch, G. 1986: Value of computerized tomography for the detection of local recurrence following surgery for rectal or rectosigmoid cancer Nederlands Tijdschrift Voor Geneeskunde 130(26): 1190-1194
Ghahramani, A.R.; Catinella, F.P. 2000: Early use of eptifibatide prior to coronary artery bypass graft surgery in a patient with unstable angina Journal of Invasive Cardiology 12 Suppl D: 10d-12d
Purnell, D.M.; Heatfield, B.M.; Trump, B.F. 1984: Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen Cancer Research 44(1): 285-292
Bussi, M.; Giordano, C.; Carlevato, M.T.; Ferrero, V.; Farri, A.; Orecchia, R. 1991: Recurrence after radiotherapy and/or surgery of carcinoma of the oropharynx and the pharynx. Possibilities of salvage surgery La Radiologia Medica 82(1-2): 137-142
Fornara, P.; Sturm, W.; Fabricius, P.G.; Schmiedt, E. 1987: Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer Der Urologe. Ausg. a 26(3): 158-161